NCT06148129View on ClinicalTrials.gov

Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients

NACompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

January 12, 2019

Primary Completion Date

October 1, 2021

Study Completion Date

March 1, 2022

Conditions
Endometrial Cancer
Interventions
DIAGNOSTIC_TEST

Tissue Biopsy

The Post-hysterectomy tissue biopsy was analyzed immunohistochemically for detection of estrogen and progesterone receptors, P53 and L1CAM

Trial Locations (1)

44519

Zagazig university, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT06148129 - Immunohistochemistry Role in Better Prognosis of Endometrial Carcinoma Patients | Biotech Hunter | Biotech Hunter